Authors:
Molteni, R
Lipska, BK
Weinberger, DR
Racagni, G
Riva, MA
Citation: R. Molteni et al., Developmental and stress-related changes of neurotrophic factor gene expression in an animal model of schizophrenia, MOL PSYCHI, 6(3), 2001, pp. 285-292
Authors:
Perez, J
Tardito, D
Racagni, G
Smeraldi, E
Zanardi, R
Citation: J. Perez et al., Protein kinase A and Rap1 levels in platelets of untreated patients with major depression, MOL PSYCHI, 6(1), 2001, pp. 44-49
Authors:
Tardito, D
Maina, G
Tura, GB
Bogetto, F
Pioli, R
Ravizza, L
Racagni, G
Perez, J
Citation: D. Tardito et al., The cAMP-dependent protein kinase substrate Rap1 in platelets from patients with obsessive compulsive disorder or schizophrenia, EUR NEUROPS, 11(3), 2001, pp. 221-225
Citation: E. Consogno et al., Modifications in brain CaM kinase II after long-term treatment with desmethylimipramine, NEUROPSYCH, 24(1), 2001, pp. 21-30
Authors:
Brunello, N
Davidson, JRT
Deahl, M
Kessler, RC
Mendlewicz, J
Racagni, G
Shalev, AY
Zohar, J
Citation: N. Brunello et al., Posttraumatic stress disorder: Diagnosis and epidemiology, comorbidity andsocial consequences, biology and treatment, NEUROPSYCHB, 43(3), 2001, pp. 150-162
Authors:
Popoli, M
Mori, S
Brunello, N
Perez, J
Gennarelli, M
Racagni, G
Citation: M. Popoli et al., Serine/threonine kinases as molecular targets of antidepressants: implications for pharmacological treatment and pathophysiology of affective disorders, PHARM THERA, 89(2), 2001, pp. 149-170
Authors:
Fumagalli, F
Santero, R
Gennarelli, M
Racagni, G
Riva, MA
Citation: F. Fumagalli et al., Decreased hippocampal BDNF expression after acute systemic injection of quinpirole, NEUROPHARM, 40(7), 2001, pp. 954-957
Authors:
Mori, S
Popoli, M
Brunello, N
Racagni, G
Perez, J
Citation: S. Mori et al., Effect of reboxetine treatment on brain cAMP- and calcium/calmodulin-dependent protein kinases, NEUROPHARM, 40(3), 2001, pp. 448-456
Authors:
Roceri, M
Molteni, R
Fumagalli, F
Racagni, G
Gennarelli, M
Corsini, GU
Maggio, R
Riva, MA
Citation: M. Roceri et al., Stimulatory role of dopamine on fibroblast growth factor-2 expression in rat striatum, J NEUROCHEM, 76(4), 2001, pp. 990-997
Authors:
de Lema, MG
Lucchesi, G
Racagni, G
Machado-Domenech, EE
Citation: Mg. De Lema et al., Changes in enzymatic activities involved in glucose metabolism by acyl-CoAs in Trypanosoma cruzi, CAN J MICRO, 47(1), 2001, pp. 49-54
Authors:
Consogno, E
Tiraboschi, E
Iuliano, E
Gennarelli, M
Racagni, G
Popoli, M
Citation: E. Consogno et al., Long-term treatment with S-adenosylmethionine induces changes in presynaptic CaM kinase II and synapsin I, BIOL PSYCHI, 50(5), 2001, pp. 337-344
Authors:
Tascedda, F
Blom, JMC
Brunello, N
Zolin, K
Gennarelli, M
Colzi, A
Bravi, D
Carra, S
Racagni, G
Riva, MA
Citation: F. Tascedda et al., Modulation of glutamate receptors in response to the novel antipsychotic olanzapine in rats, BIOL PSYCHI, 50(2), 2001, pp. 117-122
Authors:
Perez, J
Tardito, D
Mori, S
Racagni, G
Smeraldi, E
Zanardi, R
Citation: J. Perez et al., Abnormalities of cAMP signaling in affective disorders: implications for pathophysiology and treatment, BIPOL DIS, 2(1), 2000, pp. 27-36
Citation: M. Roceri et al., Calcium-dependent modulation of FGF-2 expression in cultured cerebellar granule neurons, NEUROREPORT, 11(16), 2000, pp. 3615-3619
Authors:
Garrido, MN
Racagni, G
Pereira, BMI
Rodriguez, MA
Lujan, HD
Bronia, DH
Machado-Domenech, EE
Citation: Mn. Garrido et al., Changes in Trypanosoma cruzi phospholipid turnover induced by parasite contact with cell membranes, PARASIT RES, 86(2), 2000, pp. 96-100
Authors:
Maes, M
Chiavetto, LB
Bignotti, S
Tura, GJB
Pioli, R
Boin, F
Kenis, G
Bosmans, E
de Jongh, R
Lin, AH
Racagni, G
Altamura, CA
Citation: M. Maes et al., Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics, EUR NEUROPS, 10(2), 2000, pp. 119-124
Authors:
Tardito, D
Tura, GB
Bocchio, L
Bignotti, S
Pioli, R
Racagni, G
Perez, J
Citation: D. Tardito et al., Abnormal levels of cAMP-dependent protein kinase regulatory subunits in platelets from schizophrenic patients, NEUROPSYCH, 23(2), 2000, pp. 216-219
Authors:
Ceruti, S
Franceschi, C
Barbieri, D
Malorni, W
Camurri, A
Giammarioli, AM
Ambrosini, A
Racagni, G
Cattabeni, F
Abbracchio, MP
Citation: S. Ceruti et al., Apoptosis induced by 2-chloro-adenosine and 2-chloro-2 '-deoxy-adenosine in a human astrocytoma cell line: Differential mechanisms and possible clinical relevance, J NEUROSC R, 60(3), 2000, pp. 388-400
Authors:
Brunello, N
Armitage, R
Feinberg, I
Holsboer-Trachsler, E
Leger, D
Linkowski, P
Mendelson, WB
Racagni, G
Saletu, B
Sharpley, AL
Turek, F
Van Cauter, E
Mendlewicz, J
Citation: N. Brunello et al., Depression and sleep disorders: Clinical relevance, economic burden and pharmacological treatment, NEUROPSYCHB, 42(3), 2000, pp. 107-119
Authors:
Tarricone, R
Gerzeli, S
Montanelli, R
Frattura, L
Percudani, M
Racagni, G
Citation: R. Tarricone et al., Direct and indirect costs of schizophrenia in community psychiatric services in Italy - The GISIES study, HEALTH POLI, 51(1), 2000, pp. 1-18
Authors:
Brunello, N
den Boer, JA
Judd, LL
Kasper, S
Kelsey, JE
Lader, M
Lecrubier, Y
Lepine, JP
Lydiard, RB
Mendlewicz, J
Montgomery, SA
Racagni, G
Stein, MB
Wittchen, HU
Citation: N. Brunello et al., Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment, J AFFECT D, 60(1), 2000, pp. 61-74
Authors:
Consogno, E
Dorigo, C
Racagni, G
Popoli, M
Citation: E. Consogno et al., Modification of presynaptic CaM kinase II affinity for ATP in hippocampus after long term blockade of serotonin reuptake, LIFE SCI, 67(16), 2000, pp. 1959-1967
Authors:
Perez, J
Tardito, D
Mori, S
Racagni, G
Smeraldi, E
Zanardi, R
Citation: J. Perez et al., Altered Rap1 endogenous phosphorylation and levels in platelets from patients with bipolar disorder, J PSYCH RES, 34(2), 2000, pp. 99-104
Authors:
Popoli, M
Brunello, N
Perez, J
Racagni, G
Citation: M. Popoli et al., Second messenger-regulated protein kinases in the brain: Their functional role and the action of antidepressant drugs, J NEUROCHEM, 74(1), 2000, pp. 21-33